The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xainli, J.
Right arrow Articles by King, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xainli, J.
Right arrow Articles by King, C. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Seniors' Health
The Journal of Immunology, 2002, 169: 3200-3207.
Copyright © 2002 by The American Association of Immunologists

Age-Dependent Cellular Immune Responses to Plasmodium vivax Duffy Binding Protein in Humans1

Jia Xainli*, Moses Baisor{ddagger}, Will Kastens*, Moses Bockarie{ddagger}, John H. Adams§ and Christopher L. King2,*,{dagger}

* Division of Geographic Medicine, Case Western Reserve University and {dagger} Veterans Affairs Medical Center, Cleveland, OH 44106; {ddagger} Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea; and § University of Notre Dame, South Bend, IN 46556

The Plasmodium vivax merozoite Duffy binding protein (DBP) contains a cysteine-rich region II (DBPII) that binds to the Duffy Ag receptor for chemokines on erythrocytes, which is essential for parasite invasion. Cellular immune responses to DBPII have not been reported in P. vivax endemic populations, although they may contribute to partial acquired immunity. To examine host cellular immunity to DBPII and identify major T cell epitopes, PBMCs from 107 individuals (2–68 years old) were examined for cytokine production by ELISPOT and/or ELISA to rDBP and overlapping peptides (displaced by 2 aa spanning a 170-aa region of DBPII corresponding to the critical binding motif to the Duffy Ag receptor for chemokines). In P. vivax-exposed subjects, 60 and 71% generated significant rDBP-induced IFN-{gamma} and IL-10 production, respectively, 11% stimulated IL-2, and IL-5 and IL-13 were not detected. Children <5 years of age had reduced levels and frequency of rDBP-induced IL-10 and IFN-{gamma} production compared with partially immune older children and adults (p < 0.01). Five major T cell epitopes were identified. Three of these T cell epitopes contained polymorphic residues present in the population. Peptides synthesized corresponding to these variants induced IFN-{gamma} and IL-10 production to one variant and little response to the other variant in the same individual. These results demonstrate age-dependent and variant-specific cellular immune responses to DBPII and implicate this molecule in partial acquired immunity to P. vivax in endemic populations.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
M. AREVALO-HERRERA, A. CASTELLANOS, S. S. YAZDANI, A. R. SHAKRI, C. E. CHITNIS, R. DOMINIK, and S. HERRERA
IMMUNOGENICITY AND PROTECTIVE EFFICACY OF RECOMBINANT VACCINE BASED ON THE RECEPTOR-BINDING DOMAIN OF THE PLASMODIUM VIVAX DUFFY BINDING PROTEIN IN AOTUS MONKEYS
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Xainli, J. L. Cole-Tobian, M. Baisor, W. Kastens, M. Bockarie, S. S. Yazdani, C. E. Chitnis, J. H. Adams, and C. L. King
Epitope-Specific Humoral Immunity to Plasmodium vivax Duffy Binding Protein
Infect. Immun., May 1, 2003; 71(5): 2508 - 2515.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.